Experience with estramustine phosphate.
Explore the source record for details and available documents.
Acid Phosphatase↗
SEARCH · Search PubMed
Results for “Estramustine”
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
[Hypocalcemia in a patient treated with estramustine].
Explore the source record for details and available documents.
Aged↗
Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
Explore the source record for details and available documents.
Aged↗
Re: Estramustine phosphate withdrawal syndrome with dramatic pain relief.
Explore the source record for details and available documents.
Antineoplastic Agents, Hormonal↗
[Estramustine phosphate and other chemotherapeutic agents in hormone refractory prostate cancer].
Explore the source record for details and available documents.
Antineoplastic Agents, Alkylating↗
[Prospective randomized multicenter phase III study of treatment of hormone refractory prostatic cancer: mitomycin C vs. 4-epirubicin vs. estramustine phosphate].
Explore the source record for details and available documents.
Epirubicin↗
Charge dependency of the effects of estramustine derivatives on microtubule assembly in vitro.
Explore the source record for details and available documents.
Animals↗
Intracellular effects of estramustine (Estracyt/Emcyt).
Explore the source record for details and available documents.
Chemical Phenomena↗
Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
Explore the source record for details and available documents.
Clinical Trials as Topic↗
[Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
Clinical effect of Estracyt was investigated in prostatic cancer patients. Twenty seven patients had been previously treated and 20 had not received prior treatment. Improvement rate of subjective symptoms was 85% in the previously untreated patients and that of objective findings was 85%, while those rates were 44% and 50% in the previously treated patients, respectively. Most of the adverse reactions were changes in mamma and mammary papilla which were considered to be due to the estrogenic activity.
Aged↗
Effect of a steroidal alkylating agent (estramustine phosphate) in rat ventral prostate.
Explore the source record for details and available documents.
Amino Acids↗
Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
Explore the source record for details and available documents.
Estramustine↗
[Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
Explore the source record for details and available documents.
Adenocarcinoma↗
Randomised, double-blind study of estramustine phosphate and leuprolide acetate.
Explore the source record for details and available documents.
Antineoplastic Agents↗
French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
Explore the source record for details and available documents.
Aged↗
[The effect of estramustine phosphate on carcinoma cell proliferation depends on the estrogen receptor status in the cytosol].
Explore the source record for details and available documents.
Cell Division↗
Mode of action of estramustine phosphate in hormone dependent and hormone non-dependent prostate cancer.
Explore the source record for details and available documents.
Estramustine↗
[Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
Explore the source record for details and available documents.
Aged↗